Metabolic and Bariatric Surgery ·
This case series of 1000 patients undergoing one anastomosis gastric bypass in Australia showed a mean total weight loss of 33.6% with 74% achieving type 2 diabetes remission at 1-year post-op. Complication rates, including bile reflux and marginal ulceration, were low, with no cases of internal herniation reported. Results support the efficacy and safety of this procedure in the short-medium term.
Journal Article by Hailstone L, Tovmassian D (…) Taylor C et 4 al. in Obes Surg
© 2024. Crown.
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in Metabolic and Bariatric Surgery
Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).
A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.
Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.
